Quaker Partners
Quaker Partners Management, L.P. is a private equity and venture capital firm based in Philadelphia, Pennsylvania, founded in 2002. The firm specializes in investments across all stages of company development, including seed, start-ups, and growth stages, with a focus on the life sciences sector. Quaker Partners invests in a diverse range of areas, such as biopharmaceuticals, medical devices, biotechnology, healthcare services, and health information technology. The firm actively seeks opportunities in companies that demonstrate breakthrough technology and solid intellectual property. Quaker Partners typically invests between $5 million and $25 million per company, with initial investments ranging from $2.5 million to $12 million. It prefers to lead or co-lead investment rounds and maintain active board involvement. The firm primarily targets companies located on the U.S. East Coast, particularly in the Mid-Atlantic region, while also considering opportunistic investments in the Southeast and neighboring areas.
Intact Vascular, Inc., a medical device company, develops medical devices for minimally invasive peripheral vascular procedures. The company offers Tack Endovascular System, a device that offers optimization of peripheral balloon angioplasty results during the treatment of peripheral arterial disease (PAD) and critical limb ischemia (CLI). Intact Vascular, Inc. was formerly known as Tackit Vascular LLC. The company was founded in 2011 and is based in Wayne, Pennsylvania.
Vesper Medical, Inc., a medical device company, develops minimally invasive peripheral vascular products. It offer Vesper DUO Venous Stent System, built for venous stenting. The company was founded in 2016 and is based in Wayne, Pennsylvania.
Vital Software Inc. is a provider of cloud-based software specifically designed for emergency departments in hospitals. Founded in 2017 and headquartered in Atlanta, Georgia, the company focuses on enhancing patient experiences and optimizing operational flow within emergency rooms. Its software leverages artificial intelligence to predict patient admissions and offers real-time updates regarding patients' next steps and estimated wait times. This technology allows clinicians to spend less time on electronic health records and ensures seamless communication with patients and their families, ultimately improving efficiency and potentially reducing costs for healthcare facilities.
Vesper Medical, Inc., a medical device company, develops minimally invasive peripheral vascular products. It offer Vesper DUO Venous Stent System, built for venous stenting. The company was founded in 2016 and is based in Wayne, Pennsylvania.
Intact Vascular, Inc., a medical device company, develops medical devices for minimally invasive peripheral vascular procedures. The company offers Tack Endovascular System, a device that offers optimization of peripheral balloon angioplasty results during the treatment of peripheral arterial disease (PAD) and critical limb ischemia (CLI). Intact Vascular, Inc. was formerly known as Tackit Vascular LLC. The company was founded in 2011 and is based in Wayne, Pennsylvania.
Private Equity Round in 2017
TELA Bio, Inc. is a medical technology company that specializes in the design, development, and marketing of tissue reinforcement materials for soft tissue reconstruction. The company offers a range of products, including the OviTex Reinforced Tissue Matrix, which is used for hernia repair and abdominal wall reconstruction, as well as OviTex PRS Reinforced Tissue Matrix for plastic and reconstructive surgery. Additionally, TELA Bio provides OviTex products specifically designed for laparoscopic and robotic-assisted procedures, utilizing a sterile reinforced tissue matrix derived from ovine rumen and polypropylene fiber. The company primarily markets its products through a direct sales force in the United States. Founded in 2012, TELA Bio is headquartered in Malvern, Pennsylvania.
Intact Vascular, Inc., a medical device company, develops medical devices for minimally invasive peripheral vascular procedures. The company offers Tack Endovascular System, a device that offers optimization of peripheral balloon angioplasty results during the treatment of peripheral arterial disease (PAD) and critical limb ischemia (CLI). Intact Vascular, Inc. was formerly known as Tackit Vascular LLC. The company was founded in 2011 and is based in Wayne, Pennsylvania.
Intact Vascular, Inc., a medical device company, develops medical devices for minimally invasive peripheral vascular procedures. The company offers Tack Endovascular System, a device that offers optimization of peripheral balloon angioplasty results during the treatment of peripheral arterial disease (PAD) and critical limb ischemia (CLI). Intact Vascular, Inc. was formerly known as Tackit Vascular LLC. The company was founded in 2011 and is based in Wayne, Pennsylvania.
Rapid Micro Biosystems provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers the Growth Direct System, a non-destructive method for microbial enumeration.
The company was formerly known as Genomic Profiling Systems and changed its name to Rapid Micro Biosystems in 2007. Rapid Micro Biosystems was founded in 2006 and is based in Bedford, Massachusetts.
Tarsa Therapeutics, Inc. develops therapies for the treatment and prevention of osteoporosis and related bone diseases in women. It develops TBRIA, an oral formulation of salmon calcitonin used in the treatment of postmenopausal osteoporosis. The company offers clinical programs, such as osteoporosis treatment and osteoporosis prevention programs. Tarsa Therapeutics, Inc. was formerly known as Boneco, Inc. The company was founded in 2009 and is based in Philadelphia, Pennsylvania.
Rapid Micro Biosystems provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers the Growth Direct System, a non-destructive method for microbial enumeration.
The company was formerly known as Genomic Profiling Systems and changed its name to Rapid Micro Biosystems in 2007. Rapid Micro Biosystems was founded in 2006 and is based in Bedford, Massachusetts.
Rapid Micro Biosystems provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers the Growth Direct System, a non-destructive method for microbial enumeration.
The company was formerly known as Genomic Profiling Systems and changed its name to Rapid Micro Biosystems in 2007. Rapid Micro Biosystems was founded in 2006 and is based in Bedford, Massachusetts.
Regado Biosciences is a biopharmaceutical company, engages in the discovery and development of aptamer-based antidote-controlled therapeutics. It provides REG1 that is used in patients suffering from acute coronary syndrome who undergo coronary revascularization procedures, which include coronary artery bypass grafting and percutaneous coronary intervention. It was founded in 2001 and headquartered in Durham, North Carolina.
Corridor Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutic small molecule inhibitors of arginase. Its arginase is an enzyme that competes with endothelial nitric oxide synthase for the use of the common substrate l-arginine. The company's arginase also leads to the production of ornithine which increases polyamine, stimulating cell division, and contributing to hyperplasia and fibrosis. Corridor Pharmaceuticals, Inc. was formerly known as Arginetix, Inc. and changed its name to Corridor Pharmaceuticals, Inc. on June 17, 2010. The company was founded in 2007 and is based in Lutherville, Maryland.
Neuronetics is a company dedicated to creating non-invasive therapies for psychiatric and neurological disorders through the use of MRI-strength magnetic field pulses. Established in 2003 and headquartered in Malvern, Pennsylvania, Neuronetics has achieved a significant milestone as the first company to receive FDA clearance for a non-systemic and non-invasive treatment for depression, specifically aimed at patients who have not experienced relief from previous antidepressant therapies. The company's innovative approach positions it at the forefront of developing medical devices for the treatment of mental health conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.